Northern Trust’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.97M Buy
1,284,219
+618
+0% +$1.91K ﹤0.01% 2595
2025
Q1
$4.48M Sell
1,283,601
-47,082
-4% -$164K ﹤0.01% 2480
2024
Q4
$4.35M Buy
1,330,683
+102,241
+8% +$334K ﹤0.01% 2584
2024
Q3
$4.73M Buy
1,228,442
+177,117
+17% +$682K ﹤0.01% 2508
2024
Q2
$3.25M Sell
1,051,325
-5,279
-0.5% -$16.3K ﹤0.01% 2640
2024
Q1
$2.73M Sell
1,056,604
-11,617
-1% -$30K ﹤0.01% 2805
2023
Q4
$2.67M Buy
1,068,221
+2,849
+0.3% +$7.12K ﹤0.01% 2835
2023
Q3
$2.16M Buy
1,065,372
+21,911
+2% +$44.5K ﹤0.01% 2896
2023
Q2
$2.4M Buy
1,043,461
+93,571
+10% +$215K ﹤0.01% 2912
2023
Q1
$2.88M Buy
949,890
+31,149
+3% +$94.4K ﹤0.01% 2775
2022
Q4
$2.14M Buy
918,741
+18,194
+2% +$42.4K ﹤0.01% 2962
2022
Q3
$1.72M Buy
900,547
+3,575
+0.4% +$6.83K ﹤0.01% 3099
2022
Q2
$2.43M Buy
896,972
+122,733
+16% +$333K ﹤0.01% 2950
2022
Q1
$2.31M Buy
774,239
+39,771
+5% +$119K ﹤0.01% 3028
2021
Q4
$2.86M Buy
734,468
+33,964
+5% +$132K ﹤0.01% 3034
2021
Q3
$3.01M Sell
700,504
-18,655
-3% -$80K ﹤0.01% 3052
2021
Q2
$2.18M Buy
719,159
+586,456
+442% +$1.78M ﹤0.01% 3312
2021
Q1
$442K Buy
132,703
+18,500
+16% +$61.6K ﹤0.01% 3854
2020
Q4
$405K Sell
114,203
-5,480
-5% -$19.4K ﹤0.01% 3780
2020
Q3
$375K Buy
119,683
+16,896
+16% +$52.9K ﹤0.01% 3672
2020
Q2
$188K Buy
+102,787
New +$188K ﹤0.01% 3776
2019
Q3
Sell
-293,078
Closed -$610K 4250
2019
Q2
$610K Sell
293,078
-20,682
-7% -$43K ﹤0.01% 3507
2019
Q1
$1.12M Buy
313,760
+2,642
+0.8% +$9.46K ﹤0.01% 3319
2018
Q4
$1.19M Sell
311,118
-20,590
-6% -$78.8K ﹤0.01% 3308
2018
Q3
$3.14M Buy
331,708
+35,292
+12% +$334K ﹤0.01% 2962
2018
Q2
$2.16M Buy
+296,416
New +$2.16M ﹤0.01% 3171